The Duchenne Muscular Dystrophy Global Market Report 2023, provides comprehensive information on the duchenne muscular dystrophy market across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.
Learn More On The Duchenne Muscular Dystrophy Market’s
Growth:
https://www.thebusinessresearchcompany.com/report/duchenne-muscular-dystrophy-global-market-report
As per The
Business Research Company’s Duchenne Muscular Dystrophy Global Market Report
2023, the global duchenne muscular dystrophy market size is expected to grow
from $0.98 billion in 2022 to $1.07 billion in 2023 at a compound annual growth
rate (CAGR) of 9.2%. The Russia-Ukraine war disrupted the chances of global
economic recovery from the COVID-19 pandemic, at least in the short term. The
war between these two countries has led to economic sanctions on multiple
countries, a surge in commodity prices, and supply chain disruptions, causing
inflation across goods and services and affecting many markets across the
globe. The global duchenne muscular dystrophy market size is expected to reach
$1.48 billion in 2027 at a CAGR of 8.3%.
Get A Free Sample Of The Report (Includes Graphs And
Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=10368&type=smp
Technological
advancements are a key trend gaining popularity in the Duchenne muscular
dystrophy market. Major companies operating in the Duchenne muscular dystrophy
market are focusing more on technological advancements and research and
development to sustain their position in the market. For instance, in April
2021, according to the University of Texas Southwestern's s Hamon Center for
Regenerative Science and Medicine, a US-based public academic health science
center, launched a new type of gene therapy to treat mice with Duchenne
muscular dystrophy (DMD) by using CRISPR-Cas9-based techniques to restore a
significant portion of the dystrophin protein that is missing in many DMD
patients. The scientists created a number of effective CRISPR-Cas9 nucleotide
gene editing techniques to bypass the mistaken "stop" signal,
restoring the creation of 97 % of the protein. They quickly investigated
nucleotide gene editing techniques using cardiomyocytes produced from iPS cells
of DMD patients, showing the restoration of the dystrophin protein.
The duchenne
muscular dystrophy market is segmented:
1) By Therapy:
Mutation Suppression, Exon Skipping Approach
2) By Therapeutic
Class: Molecular Based Therapies, Steroid Therapy
3) By Route of
Administration: Oral, Parenteral, Other Routes Of Administration
4) By
Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
5) By End User:
Hospitals, Homecare, Specialty Clinics, Other End-Users
North America was
the largest region in the duchenne muscular dystrophy market in 2022.
The table of contents in TBRC’s duchenne muscular dystrophy market
report includes:
1. Executive Summary
2. Duchenne Muscular Dystrophy Market Characteristics
3. Duchenne Muscular Dystrophy Market Trends And Strategies
4. Duchenne Muscular Dystrophy Market - Macro Economic Scenario
5. Duchenne Muscular Dystrophy Market Size And Growth
.
27. Duchenne
Muscular Dystrophy Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Duchenne Muscular Dystrophy
Market
29. Duchenne Muscular Dystrophy Market Future Outlook and Potential
Analysis
30. Appendix
Learn About Us:
The Business Research Company is a market intelligence
firm that pioneers in market, company, and consumer research. TBRC’s specialist
consultants are located globally and are experts in a wide range of industries
that include healthcare, manufacturing, financial services, chemicals, and
technology. The firm has offices located in the UK, the US, and India, along
with a network of proficient researchers in 28 countries. Through the report
businesses can gain a thorough understanding of the market’s size, growth rate,
major drivers and leading players.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market
Model: https://www.thebusinessresearchcompany.com/global-market-model
No comments:
Post a Comment